Prevalence and Endoscopic Documentation of Helicobacter pylori and Gastric Precancerous Conditions in Routine Gastroscopy with Biopsies: A Cross-Sectional Study
4 affiliations
- 1Department of Gastroenterology University Hospital Augsburg Augsburg Bavaria Germany
- 2Medical Faculty University Hospital Augsburg Augsburg Bavaria Germany
- 3Institute of Digital Medicine University Hospital Augsburg Augsburg Bavaria Germany
- 4Institute of Epidemiology University Hospital Augsburg Augsburg Bavaria Germany
Abstract
Background: In Western countries without screening programs, Helicobacter pylori infection, gastric atrophy, and intestinal metaplasia must be detected opportunistically during endoscopy, yet real-world data on how reliably this occurs are scarce. We determined their histologic prevalence among biopsied diagnostic gastroscopies and how completely they are recorded in routine endoscopy reports.
Materials and Methods: Retrospective single-center cross-sectional study of all diagnostic gastroscopies with gastric biopsies at a tertiary university hospital (2016–2025). Documentation of each lesion was compared with institutional histopathology reports. As only biopsied examinations were eligible, concordance measures reporting completeness. Prevalence was analyzed at patient level ( n = 9,852) and concordance at examination level ( n = 11,381).
Results: H. pylori infection or any gastric precancerous condition was present in 31.4% of patients ( H. pylori 11.5%, atrophy 6.6%, intestinal metaplasia 21.5%). A corresponding finding was recorded in the endoscopy report in 9.6% (95% CI 8.0–11.4) of H. pylori -positive, 9.2% (8.1–10.3) of metaplasia-positive and 49.4% (45.8–52.9) of atrophy-positive examinations. Counting rapid urease tests, which indicate H. pylori testing but not written mucosal suspicion, increased documentation to 46.0%. Results were similar with antrum-and-corpus sampling (90.7%; ≤0.7 percentage points). The publication of MAPS-II or newer endoscopy generations did not increase documentation substantially.
Conclusion: H. pylori infection and gastric precancerous conditions affected nearly one-third of biopsied patients, yet most histologically confirmed findings were not explicitly documented at endoscopy. Closing this documentation gap should be a priority for integrating gastric cancer risk assessment into routine endoscopic reporting.
Related
- Comparative Progression of Precancerous Gastric Lesions in Autoimmune and Helicobacter pylori-Associated Gastritis: A Longitudinal Cohort from Eastern Europe
- Incidentally Detected Persistent Helicobacter heilmannii Gastritis in a Korean Woman With a Normal Endoscopic Examination: Successful Eradication After Salvage Therapy
- Association Between Intermittent Water Supply and Helicobacter pylori Prevalence: A Global Ecological Study
- Helicobacter pylori, Betel Quid Chewing, and Endoscopic Pathology in Dyspeptic Patients: A Cross-Sectional Analytical Study.
- Prevalence and co-detection of Helicobacter pylori, Epstein–Barr virus, and human papillomavirus in gastric tissues: a cross-sectional study from Yazd, Iran (2019–2022)
BibTeX
@article{roser2026prevalence,
title = {{Prevalence and Endoscopic Documentation of Helicobacter pylori and Gastric Precancerous Conditions in Routine Gastroscopy with Biopsies: A Cross-Sectional Study}},
author = {David Andreas Roser and Hanna Ganthaler and Andreas Probst and Yevgeniia Ignatenko and Dennis Freuer and Helmut Messmann and Christoph Römmele},
journal = {Endoscopy International Open},
year = {2026},
month = nov,
doi = {10.1055/a-2992-1623},
url = {https://doi.org/10.1055/a-2992-1623},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Prevalence and Endoscopic Documentation of Helicobacter pylori and Gastric Precancerous Conditions in Routine Gastroscopy with Biopsies: A Cross-Sectional Study
AU - David Andreas Roser
AU - Hanna Ganthaler
AU - Andreas Probst
AU - Yevgeniia Ignatenko
AU - Dennis Freuer
AU - Helmut Messmann
AU - Christoph Römmele
PY - 2026
DA - 2026/11/06
JO - Endoscopy International Open
DO - 10.1055/a-2992-1623
UR - https://doi.org/10.1055/a-2992-1623
AB - Background: In Western countries without screening programs, Helicobacter pylori infection, gastric atrophy, and intestinal metaplasia must be detected opportunistically during endoscopy, yet real-world data on how reliably this occurs are scarce. We determined their histologic prevalence among biopsied diagnostic gastroscopies and how completely they are recorded in routine endoscopy reports. Materials and Methods: Retrospective single-center cross-sectional study of all diagnostic gastroscopies with gastric biopsies at a tertiary university hospital (2016–2025). Documentation of each lesion was compared with institutional histopathology reports. As only biopsied examinations were eligible, concordance measures reporting completeness. Prevalence was analyzed at patient level ( n = 9,852) and concordance at examination level ( n = 11,381). Results: H. pylori infection or any gastric precancerous condition was present in 31.4% of patients ( H. pylori 11.5%, atrophy 6.6%, intestinal metaplasia 21.5%). A corresponding finding was recorded in the endoscopy report in 9.6% (95% CI 8.0–11.4) of H. pylori -positive, 9.2% (8.1–10.3) of metaplasia-positive and 49.4% (45.8–52.9) of atrophy-positive examinations. Counting rapid urease tests, which indicate H. pylori testing but not written mucosal suspicion, increased documentation to 46.0%. Results were similar with antrum-and-corpus sampling (90.7%; ≤0.7 percentage points). The publication of MAPS-II or newer endoscopy generations did not increase documentation substantially. Conclusion: H. pylori infection and gastric precancerous conditions affected nearly one-third of biopsied patients, yet most histologically confirmed findings were not explicitly documented at endoscopy. Closing this documentation gap should be a priority for integrating gastric cancer risk assessment into routine endoscopic reporting.
SN - 2364-3722
SN - 2196-9736
ER -